GlassScriptPhysician profile
Ichiro Yuki
NPI 1205312642
$3,539.00
in general payments reported to CMS, 2019-2025
7 companies · $1,672 in 2025
The $1,672 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.99 · 2021: $1,047 · 2022: $35.32 · 2023: $338 · 2024: $432 · 2025: $1,672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,512 · Food and Beverage: $930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,512.00 |
| Food and Beverage | $929.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,802.75 | 2021-2025 | Onyx 18, Pipeline |
| Asahi Intecc Co., LTD. | $1,000.00 | 2021 | |
| Microvention, INC. | $313.13 | 2023-2024 | Web Aneurysm Embolization System, Stent, Lvis Junior |
| Stryker Corporation | $213.32 | 2021-2025 | Surpass Evolve |
| Silk Road Medical, INC. | $159.49 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Depuy Synthes Sales INC. | $35.32 | 2022 | |
| Balt USA, LLC | $14.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ichiro Yuki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.